ClinicalTrials.Veeva

Menu

Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis

P

Peking University

Status

Not yet enrolling

Conditions

Allergic Bronchopulmonary Aspergillosis

Study type

Observational

Funder types

Other

Identifiers

NCT06645210
M2024692

Details and patient eligibility

About

To understand the current diagnosis and treatment status of ABPA patients, observe their clinical characteristics, prognosis, and treatment outcomes, and identify the relevant factors for poor prognosis in patients.

Enrollment

300 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Meeting the diagnosis of ABPA according to the ABPA diagnostic criteria specified by the ISHAM-ABPA working group in 2024

Exclusion criteria

ABPA patients who are not first diagnosed in the center

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems